These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17459556)

  • 41. Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.
    Pokorná Z; Kollárová-Brázdová P; Lenčová-Popelová O; Jirkovský E; Kubeš J; Mazurová Y; Adamcová M; Holečková M; Palička V; Šimůnek T; Štěrba M
    Clin Sci (Lond); 2022 Jan; 136(1):139-161. PubMed ID: 34878093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
    Chen YL; Kong X; Xie Y; Hider RC
    J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.
    Hašková P; Koubková L; Vávrová A; Macková E; Hrušková K; Kovaříková P; Vávrová K; Simůnek T
    Toxicology; 2011 Nov; 289(2-3):122-31. PubMed ID: 21864640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
    Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
    Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat.
    Rahimi Balaei M; Momeny M; Babaeikelishomi R; Ejtemaei Mehr S; Tavangar SM; Dehpour AR
    Eur J Pharmacol; 2010 Sep; 641(2-3):193-8. PubMed ID: 20534381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron-chelator complexes as iron sources for early developing human erythroid precursors.
    Leimberg JM; Prus E; Link G; Fibach E; Konijn AM
    Transl Res; 2008 Feb; 151(2):88-96. PubMed ID: 18201676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits.
    Gersl V; Hrdina R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):49-55. PubMed ID: 7784798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
    Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. caffeic, chlorogenic and rosmarinic acids.
    Chlopcíková S; Psotová J; Miketová P; Sousek J; Lichnovský V; Simánek V
    Phytother Res; 2004 May; 18(5):408-13. PubMed ID: 15174003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release.
    Golenser J; Domb A; Teomim D; Tsafack A; Nisim O; Ponka P; Eling W; Cabantchik ZI
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1127-35. PubMed ID: 9190845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities.
    Hrušková K; Potůčková E; Opálka L; Hergeselová T; Hašková P; Kovaříková P; Šimůnek T; Vávrová K
    Chem Res Toxicol; 2018 Jun; 31(6):435-446. PubMed ID: 29766723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron.
    Lesnikov VA; Abbasi N; Lesnikova MP; Lazaro CA; Campbell JS; Fausto N; Deeg HJ
    Apoptosis; 2006 Jan; 11(1):79-87. PubMed ID: 16374550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel iron chelator that does not induce HIF-1 activity.
    Creighton-Gutteridge M; Tyrrell RM
    Free Radic Biol Med; 2002 Aug; 33(3):356-63. PubMed ID: 12126757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
    Adamcová M; Šimůnek T; Kaiserová H; Popelová O; Štěrba M; Potáčová A; Vávrová J; Maláková J; Geršl V
    Toxicology; 2007 Jul; 237(1-3):218-228. PubMed ID: 17587482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity.
    Mojzisová G; Mirossay L; Kucerová D; Kyselovic J; Mirossay A; Mojzis J
    Phytother Res; 2006 Feb; 20(2):110-4. PubMed ID: 16444662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
    Vávrová A; Popelová O; Stěrba M; Jirkovský E; Hašková P; Mertlíková-Kaiserová H; Geršl V; Simůnek T
    Arch Toxicol; 2011 May; 85(5):525-35. PubMed ID: 21046361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.
    Xin YF; Zhou GL; Shen M; Chen YX; Liu SP; Chen GC; Chen H; You ZQ; Xuan YX
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):421-6. PubMed ID: 17971065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
    Xu X; Sutak R; Richardson DR
    Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.